IR BioSciences Holdings, Inc. (IRBO) Closes New $5 Million Funding Round
8/11/2008 6:39:23 AM
More...
|
IR BioSciences Holdings, Inc. (IRBO) Appoints Former VaxGen, Inc. (VXGN) Chief Executive Lance K. Gordon Ph.D. to Its Board of Directors
5/15/2007 10:26:22 AM
More...
|
IR BioSciences Holdings, Inc. (IRBO) Announces Promising Data from Study of Its Compound Homspera
5/7/2007 2:56:07 PM
More...
|
IR BioSciences Holdings, Inc. (IRBO) Appoints Dr. Robert Hariri to Its Board of Directors
4/25/2007 2:03:56 PM
More...
|
IR BioSciences Holdings, Inc. (IRBO) Appoints Celgene Corporation (CELG) Executive Dr. Robert Hariri to Its Board of Directors
4/25/2007 10:32:25 AM
More...
|
IR BioSciences Holdings, Inc. (IRBO) Responds to the Recently Cancelled Acute Radiation Syndrome (ARS) RFP by DHHS
3/14/2007 2:31:24 PM
More...
|
IR BioSciences Holdings, Inc. (IRBO) Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
3/8/2007 1:20:09 PM
More...
|
IR BioSciences Holdings, Inc. (IRBO) to Collaborate with Leading Clinical Services Company to Evaluate Radilex(TM) in Low-Level Radiation Exposure
2/26/2007 1:09:49 PM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) And Oak Ridge National Laboratory Announce Initial Results From Radilex(TM) Testing
6/1/2006 10:41:00 AM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) Plans Response To Upcoming Department of Health and Human Services RFP For Advanced Development Of New Antiviral Agents For Influenza
5/31/2006 12:43:27 PM
More...
|
|